Skip to main content
. 2008 Aug 29;295(5):H1825–H1833. doi: 10.1152/ajpheart.495.2008

Fig. 3.

Fig. 3.

Infarct sizes (ISs) in vehicle-, ATL146e-, and CGS-21680-treated A2A adenosine receptor (A2AAR)+/+ and A2AAR−/− hearts. Treatment with either ATL146e or CGS-21680 significantly decreased IS in A2AAR+/+ [wild type (WT)] hearts (P < 0.05), but ATL146e had no effect in A2AAR−/− [knockout (KO)] hearts. IS is presented as the percent area at risk (%AAR). n = 20 vehicle-treated WT hearts, 20 ATL146e-treated WT hearts, 8 CGS-21680-treated hearts, 8 vehicle-treated KO hearts, and 8 ATL146e-treated KO hearts. *P < 0.05 by one-way ANOVA.